Shugoshin protein maintains proper gene expression in subtelomeres

A research group discovered a new function of the chromosomal terminus, which may lead to the clarification of the mechanism for developing abnormal telomere structure such as multiple malformation and mental retardation.

DNA forms chromosome by combining with various proteins and other matters. Telemere, the chromosome ends, is playing an inevitable role in maintaining the life including germ cells or cell senescence. Besides, the function of subtelomere, the telomere-adjacent region, has not yet been clarified although abnormal telomere structure such as multiple malformation and mental retardation exists.

A research group led by Junko Kanoh, Associate Professor at Institute for Protein Research, Osaka University in cooperation with the Graduate School of Science, Graduate School of Frontier Biosciences of Osaka University, National Institute of Information and Communications Technology, and The University of Tokyo elucidated a function of the telomere.

Specifically, this group found that a protein called Shugoshin binds with subtelomeres and that through which the proper gene expression in subtelomeres is maintained. This group also clarified that Shugoshin controls DNA replication (the process by which DNA makes a copy of itself during cell division) in subtelomeres as well as higher-order structure of chromosomes.

The clarification of the mystery of whether Shugoshin controls the subtelomeres or similar control systems work in humans as well may lead to the elucidation of a mechanism for developing abnormal telomere structure such as multiple malformation and mental retardation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma